Webinar: Can AI replace humans in pharmacovigilance?

The webinar will explore how AI can transform pharmacovigilance by enhancing efficiency, reducing errors, and addressing challenges such as software costs, data...

The pandemic caused a reshuffle among the world’s vaccine giants – here is the new top list

Fuelled by the pandemic, the power balance in the global vaccine market has completely changed in recent years, a survey from Fierce Pharma shows

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

New diagnostic rules raise concerns

In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagno...

Analys av metaboliter hjälp för att skräddarsy behandlingar

Genom att studera kroppens nedbrytningsprodukter, metaboliter, kan behandlingar bättre skräddarsys för patientens specifika behov och förutsättningar. Det säger...

Sanofi ingår samarbete om radiofarmaka – investerar miljardbelopp

Franska läkemedelsföretaget Sanofi och Orano Med har ingått ett avtal om utvecklingen av radioligand-terapier. Sanofi investerar samtidigt 300 miljoner euro i b...

Don't miss ZEISS Quality Innovation Days

Digital event April 15-19, 2024.

Han är ny på AAX Biotech

Startup-bolaget AAX Biotech har rekryterat Juan Astorga-Wells till tjänsten som Senior Manager of Science & Development.

Samuel Lagercrantz: ”Bolag i det fördolda får branschen att blomma”

Det finns en kategori företag som sällan står i rampljuset, men som sysselsätter många personer inom life science-sektorn och som har stor betydelse för branschen.

Tools of Science

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

Vaccinskeptiker ny ordförande för amerikansk covid-kommitté

Enligt professor Retsef Levi kan mRNA-vacciner orsaka allvarlig skada och död och bör därför omedelbart dras tillbaka. Nu har han utsetts till att leda arbetsgr...

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

Uncertainty about the government’s life science work

The government’s national coordinator for life science, Jenni Nordborg, left her position almost four months ago. No one has yet succeeded her, and now question...

Cantargia utser Hilde Steineger till ny vd

Det Lundbaserade forskningsbolaget Cantargia har utsett Hilde Steineger till ny vd.

Business Sweden: “Companies have a lot to offer in data-driven precision medicine”

Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.

Introduction of ZEISS Imaging Systems for Super-Resolution

Webinar recording about the ZEISS Lattice SIM technology.

A vaccine the world is waiting for: “It can change the lives of many”

Manager.

Tougher competition as the Novo Nordisk Foundation broadens its programme

Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...

BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”

he also highlights a study that points out that companies with a high degree of interaction with other companies achieve greater success.

Stor kongress om framtidsutsikter igång i Lund

Vad sker i framtiden inom svensk och dansk life science? Det diskuteras i dag vid eventet The Future of Swedish and Danish Life Science i Lund.

Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”

”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...

Nanexa develops depot formulation of the diabetes and obesity drug Saxenda

Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...

Kroniskt trötthetssyndrom kopplas till gener i brittisk studie

Brittiska forskare har identifierat genetiska faktorer som kan kopplas till kroniskt trötthetssyndrom.